Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
about
Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determinationHuman RSPO1/R-spondin1 is expressed during early ovary development and augments β-catenin signalingWnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergyMutation analysis of FOXF2 in patients with disorders of sex development (DSD) in combination with cleft palateOver- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarismCTNNB1 signaling in sertoli cells downregulates spermatogonial stem cell activity via WNT4Mammalian sex determination—insights from humans and mice.Testis development requires the repression of Wnt4 by Fgf signalingFollistatin operates downstream of Wnt4 in mammalian ovary organogenesisOvarian Transcriptome Analysis of Portunus trituberculatus Provides Insights into Genes Expressed during Phase III and IV DevelopmentNovel markers of early ovarian pre-granulosa cells are expressed in an Sry-like patternCloning and characterization of wnt4a gene and evidence for positive selection in half-smooth tongue sole (Cynoglossus semilaevis).Dysregulation of WNT/CTNNB1 and PI3K/AKT signaling in testicular stromal cells causes granulosa cell tumor of the testisDifferential expression of WNT4 in testicular and ovarian development in a marsupialCloning and expression of R-Spondin1 in different vertebrates suggests a conserved role in ovarian developmentComparative analysis of the mammalian WNT4 promoterEstrogen receptor 1 (ESR1; ERα), not ESR2 (ERβ), modulates estrogen-induced sex reversal in the American alligator, a species with temperature-dependent sex determination.Genome-wide identification of CBX2 targets: insights in the human sex development network.To beta or not to beta: canonical beta-catenin signaling pathway and ovarian developmentIdentification of de novo copy number variants associated with human disorders of sexual development.The pathway to femaleness: current knowledge on embryonic development of the ovary.Copy number variation in patients with disorders of sex development due to 46,XY gonadal dysgenesis.Transcriptome analysis of the differences in gene expression between testis and ovary in green mud crab (Scylla paramamosain)Sex reversal in C57BL/6J XY mice caused by increased expression of ovarian genes and insufficient activation of the testis determining pathway.Disorders of sex development: new genes, new concepts.Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determinationR-spondins are involved in the ovarian differentiation in a teleost, medaka (Oryzias latipes).The genetics of male undermasculinization.The genetic make-up of ovarian development and function: the focus on the transcription factor FOXL2.Report of fertility in a woman with a predominantly 46,XY karyotype in a family with multiple disorders of sexual development.Expression and functional analysis of Dkk1 during early gonadal development.DSDs: genetics, underlying pathologies and psychosexual differentiation.Translational genetics for diagnosis of human disorders of sex developmentSexually dimorphic regulation of inhibin beta B in establishing gonadal vasculature in mice.Adrenocortical stem and progenitor cells: implications for adrenocortical carcinomaThe genetic basis for sex differences in human behaviour: role of the sex chromosomes.Multigeneration Inheritance through Fertile XX Carriers of an NR0B1 (DAX1) Locus Duplication in a Kindred of Females with Isolated XY Gonadal Dysgenesis.Building pathways for ovary organogenesis in the mouse embryo.Association of WNT4 polymorphisms with endometriosis in infertile patientsWinding through the WNT pathway during cellular development and demise
P2860
Q21092773-3D6DB0B5-F4BE-4911-9598-C637A57171A3Q21135743-98FE9CBC-C152-48DF-A340-E8A1646A0228Q24319025-D82CC320-D528-4F21-8522-98F064BF8EFFQ24319895-25E1DA82-E4BD-4C31-AA1B-B44B24164D34Q24531513-8CAE3DFB-84E2-4DF3-9445-8E4B7FC383A8Q27310305-368C6A00-A41F-4FCD-8E01-8EF3A1D4B8B5Q27691819-912EF23F-2A22-4B39-B8C0-99060CFEA658Q28268953-0993CFC1-9326-49EB-A20B-25EB7F607D19Q28510588-493627B9-75C4-4A95-92C9-342753A9C134Q28550014-69F2E021-1299-4AE1-B0FD-DF8F4E116E5EQ28590895-280ADDA9-FA9A-4DBA-BC97-C61566BF6200Q30390203-32C1E979-D4DC-44EF-9362-008F3A3CD6C1Q30436220-3FE897B1-FFDB-4B3E-8E0A-712BDEEC804DQ33259111-A562C794-9C8E-4DAD-9D20-B4D98FE2DA68Q33354658-8C71AF16-5679-45B0-AAB6-3CB08D50206DQ33500381-EDF5A2BC-1A2D-42C4-9756-4622AC239354Q33569715-A99753AC-FD71-4620-A837-42AF881F58F4Q33631793-D0EA581B-A7CB-433C-B70A-84A3875A1C9BQ33722825-4C1D013B-88F1-41D0-92A7-94798047C811Q33737564-0AC7BBBA-497D-4AD9-8575-CA2922F4813CQ33815432-6F67FC05-4AD2-457E-846E-E57A7FA71D0EQ33847708-95A708C6-F25B-4EAB-8F7D-8FCA96E19D26Q34012000-36F2B7B1-BA64-42B2-AA34-C8DA9DCD8DAFQ34229712-B0AEACAF-39D1-4327-833A-131D844AF071Q34321287-87775294-D5B2-43C9-9DB7-739C0B8D2340Q34381676-C2A4E516-DB6F-47DC-B83F-29BF1B42C64EQ34502841-E0AA17A4-DCB6-452C-8650-2F4ABBB44455Q34534452-C7BFBD76-7EF7-44C6-94C6-0F21A06177EAQ34539732-F347B8EC-EF87-4699-B831-5CD565BBF7E6Q34713339-4769357F-2582-496D-A4E9-00F8D21BCCFAQ35063567-FDF7FF0D-C7BA-4C6D-A8E9-70C2C6C3E7DFQ35637370-3B63E125-2B21-4D4E-961F-9673651F7D83Q35660382-A6343CE7-20B4-47B9-A8FB-322021066AD9Q35674942-0F0BF064-F67F-4F24-B41D-4BA7EA819542Q35782788-1B8D3A51-E1C3-4A19-952E-736F6B1F2B4BQ35794311-BBB10D65-5FD4-4F30-A74A-8397A0A392DFQ35821261-986E6B12-F052-4D63-B5EB-62698EF24D11Q36103926-7ADEAB40-C54B-485D-9D8D-A0D52CAC06F5Q36127701-713523F4-771F-4593-BC88-511E749544BEQ36305544-0A5A8016-3421-4DF9-B3AB-5B91F6C0466F
P2860
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans
@nl
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
@ast
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
@en
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
@en-gb
type
label
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans
@nl
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
@ast
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
@en
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
@en-gb
prefLabel
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans
@nl
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
@ast
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
@en
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
@en-gb
P2093
P2860
P50
P921
P356
P1476
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans
@en
P2093
Mohammed M
P2860
P304
P356
10.1086/320125
P407
P577
2001-03-29T00:00:00Z